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Background: Transapical aortic valve replacement (TA-AVR) offers a solution for aortic stenosis patients with poor vascular access. Recent reports 
indicate that TA-AVR is associated with higher levels of myocardial enzyme leakage and that procedural outcomes may be inferior to the transfemoral 
approach. We sought to evaluate apical regional wall motion abnormality (ARWMA) at the apical access site and to assess whether it has any 
consequence on patient outcome.
Methods: We retrospectively assessed ARWMA by three standard echo long axis views in patients undergoing TA-AVR (n=58). Apical RWMA was 
assessed on pre-procedure (baseline), immediate post- (early, 6±1 d) and late post-procedure (late, 124±72 d) exams. ARWMA was categorized as 
normal, hypokinesis or akinesis.
Results: Among 58 TA-AVR patients, 12 (21%) had ARWMA (10 had hypokinesis, 2 had akinesis). Of those 12 with early RWMA of the apex, 7 (58%) 
had full recovery in the late follow-up. As shown in the Table, patients who developed ARWMA had similar baseline characteristics as compared to 
patients with normal apical movement. Post-procedural serum cardiac markers were comparable between the two groups. Patients with ARWMA had 
lower EF at early follow up, but similar 2-month mortality.
Conclusion: This cohort indicates that transient ARWMA following TA-AVR occurs in nearly 1/4 of patients. However, this localized RWMA 
abnormality is not correlated with enzyme leakage, and does not seem to adversely affect patient outcome.
 
